Lucyna Korman

496 total citations
27 papers, 404 citations indexed

About

Lucyna Korman is a scholar working on Rheumatology, Immunology and Oncology. According to data from OpenAlex, Lucyna Korman has authored 27 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Rheumatology, 15 papers in Immunology and 6 papers in Oncology. Recurrent topics in Lucyna Korman's work include Rheumatoid Arthritis Research and Therapies (11 papers), Systemic Lupus Erythematosus Research (6 papers) and Psoriasis: Treatment and Pathogenesis (5 papers). Lucyna Korman is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (11 papers), Systemic Lupus Erythematosus Research (6 papers) and Psoriasis: Treatment and Pathogenesis (5 papers). Lucyna Korman collaborates with scholars based in Poland, Croatia and Malta. Lucyna Korman's co-authors include Piotr Wiland, Jerzy Świerkot, Beata Nowak, Katarzyna Bogunia‐Kubik, Katarzyna Gębura, Barbara Wysoczańska, Magdalena Szmyrka−Kaczmarek, Anna Pokryszko‐Dragan, Ewa Gruszka and Marta Madej and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Annals of the Rheumatic Diseases.

In The Last Decade

Lucyna Korman

27 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lucyna Korman Poland 12 213 163 69 65 64 27 404
Tal Gazitt Israel 12 221 1.0× 224 1.4× 26 0.4× 59 0.9× 37 0.6× 31 437
Viviana Antonella Pacucci Italy 9 302 1.4× 208 1.3× 53 0.8× 31 0.5× 35 0.5× 17 466
Bineta Ly France 10 86 0.4× 143 0.9× 46 0.7× 30 0.5× 62 1.0× 15 384
Alessandra Penatti Italy 7 241 1.1× 226 1.4× 21 0.3× 49 0.8× 49 0.8× 10 481
AA Bengtsson Sweden 9 207 1.0× 224 1.4× 31 0.4× 47 0.7× 44 0.7× 15 367
Saloua Zrioual France 7 179 0.8× 341 2.1× 54 0.8× 102 1.6× 111 1.7× 8 520
Y.W. Song South Korea 7 274 1.3× 271 1.7× 49 0.7× 38 0.6× 75 1.2× 25 525
Shuji Akizuki Japan 11 222 1.0× 247 1.5× 41 0.6× 35 0.5× 53 0.8× 48 552
Delphine Mariotte France 10 86 0.4× 114 0.7× 96 1.4× 19 0.3× 68 1.1× 31 347
CWK Lam China 4 260 1.2× 354 2.2× 49 0.7× 35 0.5× 64 1.0× 5 474

Countries citing papers authored by Lucyna Korman

Since Specialization
Citations

This map shows the geographic impact of Lucyna Korman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucyna Korman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucyna Korman more than expected).

Fields of papers citing papers by Lucyna Korman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucyna Korman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucyna Korman. The network helps show where Lucyna Korman may publish in the future.

Co-authorship network of co-authors of Lucyna Korman

This figure shows the co-authorship network connecting the top 25 collaborators of Lucyna Korman. A scholar is included among the top collaborators of Lucyna Korman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucyna Korman. Lucyna Korman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kokot, Izabela, Sylwester Mazurek, Agnieszka Piwowar, et al.. (2024). Comparative profiling of serum biomarkers and ATR-FTIR spectroscopy for differential diagnosis of patients with rheumatoid and psoriatic arthritis − a pilot study. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 321. 124654–124654. 4 indexed citations
2.
Kratz, Ewa Maria, et al.. (2024). Glycosylation Pattern of Serum Clusterin in Psoriatic Arthritis and Rheumatoid Arthritis—The Search for New Diagnostic Glycomarkers. International Journal of Molecular Sciences. 25(23). 13060–13060. 2 indexed citations
3.
Świerkot, Jerzy, et al.. (2022). The Risk of Autoimmunity Development following mRNA COVID-19 Vaccination. Viruses. 14(12). 2655–2655. 5 indexed citations
4.
Madej, Marta, et al.. (2022). The assessment of the risk of COVID-19 infection and its course in the medical staff of a COVID-only and a non-COVID hospital. Advances in Clinical and Experimental Medicine. 31(9). 981–989. 2 indexed citations
5.
6.
Iwaszko, Milena, Jerzy Świerkot, Barbara Wysoczańska, et al.. (2021). Relationship Between Interleukin-6 −174G/C Genetic Variant and Efficacy of Methotrexate Treatment in Psoriatic Arthritis Patients. Pharmacogenomics and Personalized Medicine. Volume 14. 157–166. 6 indexed citations
7.
Świerkot, Jerzy, et al.. (2021). Usefulness of noninvasive diagnostic procedures for assessment of methotrexate hepatotoxicity in patients with rheumatoid arthritis. Rheumatology International. 42(4). 631–638. 8 indexed citations
8.
Iwaszko, Milena, Jerzy Świerkot, Marta Dratwa, et al.. (2020). Association of MICA-129Met/Val polymorphism with clinical outcome of anti-TNF therapy and MICA serum levels in patients with rheumatoid arthritis. The Pharmacogenomics Journal. 20(6). 760–769. 14 indexed citations
9.
Radwan‐Oczko, Małgorzata, et al.. (2019). Periodontal disease and influence of periodontal treatment on disease activity in patients with rheumatoid arthritis and spondyloarthritis. Rheumatology International. 40(3). 455–463. 29 indexed citations
10.
Szmyrka−Kaczmarek, Magdalena, Anna Pokryszko‐Dragan, Krzysztof Słotwiński, et al.. (2018). Cognitive impairment, event-related potentialsand immunological status in patientswith systemic lupus erythematosus. Advances in Clinical and Experimental Medicine. 28(2). 185–192. 10 indexed citations
11.
Świerkot, Jerzy, et al.. (2018). Autoantibody and metalloproteinase activity in early arthritis. Clinical Rheumatology. 38(3). 827–834. 4 indexed citations
12.
Świerkot, Jerzy, Beata Nowak, Anna Czarny, et al.. (2016). The Activity of JAK/STAT and NF-κB in Patients with Rheumatoid Arthritis. Advances in Clinical and Experimental Medicine. 25(4). 709–717. 36 indexed citations
13.
Świerkot, Jerzy, Anna Czarny, Ewa Zaczyńska, et al.. (2015). Activity of JAK/STAT and NF-kB in patients with axial spondyloarthritis. Postępy Higieny i Medycyny Doświadczalnej. 69. 1291–1298. 8 indexed citations
14.
Madej, Marta, et al.. (2015). Cytokine profiles in axial spondyloarthritis. SHILAP Revista de lepidopterología. 53(1). 9–13. 20 indexed citations
15.
Bogunia‐Kubik, Katarzyna, Jerzy Świerkot, Barbara Wysoczańska, et al.. (2014). IL-17A, IL-17F and IL-23R Gene Polymorphisms in Polish Patients with Rheumatoid Arthritis. Archivum Immunologiae et Therapiae Experimentalis. 63(3). 215–221. 68 indexed citations
16.
17.
Gębura, Katarzyna, Milena Iwaszko, Jerzy Świerkot, et al.. (2014). Significance of association of HLA-C and HLA-E with psoriatic arthritis. Human Immunology. 75(12). 1188–1191. 15 indexed citations
18.
Nowak, Beata, et al.. (2013). Anti-ox-LDL antibodies and anti-ox-LDL-B2GPI antibodies in patients with systemic lupus erythematosus.. PubMed. 21(3). 331–5. 17 indexed citations
19.
Świerkot, Jerzy, et al.. (2012). Clinical immunology<br>Effect of methotrexate on serum levels of anti-CCP antibodies and different classes of rheumatoid factors in rheumatoid arthritis patients. Central European Journal of Immunology. 37(3). 253–257. 3 indexed citations
20.
Szmyrka−Kaczmarek, Magdalena, Anna Pokryszko‐Dragan, Bartłomiej Pawlik, et al.. (2011). Antinuclear and antiphospholipid antibodies in patients with multiple sclerosis. Lupus. 21(4). 412–420. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tal Gazitt Breakdown of academic impact, for papers by Viviana Antonella Pacucci Breakdown of academic impact, for papers by Bineta Ly Breakdown of academic impact, for papers by Alessandra Penatti Breakdown of academic impact, for papers by AA Bengtsson Breakdown of academic impact, for papers by Saloua Zrioual Breakdown of academic impact, for papers by Y.W. Song Breakdown of academic impact, for papers by Shuji Akizuki Breakdown of academic impact, for papers by Delphine Mariotte Breakdown of academic impact, for papers by CWK Lam
Rankless by CCL
2026